• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic carbonic acids and derivatives Organic carbonic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic carbonic acids and derivatives

Introduction to Chloro2-(Prop-2-yn-1-yloxy)ethoxymethanone (CAS No. 2174001-17-1)

Chloro2-(prop-2-yn-1-yloxy)ethoxymethanone (CAS No. 2174001-17-1) is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds potential applications in various therapeutic areas, particularly in the development of novel drugs and drug delivery systems.

The chemical structure of chloro2-(prop-2-yn-1-yloxy)ethoxymethanone consists of a chloromethyl ketone moiety linked to a propargyloxyethoxy group. The presence of the propargyloxy functional group imparts significant reactivity and versatility to the molecule, making it an attractive candidate for chemical synthesis and biological studies. The chloromethyl ketone functionality, on the other hand, can participate in various chemical reactions, including nucleophilic addition and substitution reactions, which are crucial for the synthesis of complex organic molecules.

Recent research has highlighted the potential of chloro2-(prop-2-yn-1-yloxy)ethoxymethanone in the development of targeted drug delivery systems. The compound's ability to undergo click chemistry reactions, particularly with azide-functionalized molecules, makes it a valuable building block for the construction of bioconjugates. These bioconjugates can be designed to target specific cells or tissues, enhancing the efficacy and reducing the side effects of therapeutic agents.

In the context of medicinal chemistry, chloro2-(prop-2-yn-1-yloxy)ethoxymethanone has been explored for its potential as a prodrug precursor. Prodrugs are inactive compounds that are converted into active drugs within the body through metabolic processes. The propargyloxy group in chloro2-(prop-2-yn-1-yloxy)ethoxymethanone can be modified to introduce various functional groups that enhance solubility, stability, and bioavailability. This property is particularly useful in the development of prodrugs for oral administration, where improved solubility and stability are critical for effective drug delivery.

Furthermore, studies have shown that chloro2-(prop-2-yn-1-yloxy)ethoxymethanone exhibits promising antiviral activity against several viral strains. The compound's ability to interfere with viral replication processes makes it a potential candidate for the development of antiviral drugs. Research in this area is ongoing, with a focus on optimizing the compound's structure to enhance its antiviral potency and selectivity.

The synthesis of chloro2-(prop-2-yn-1-yloxy)ethoxymethanone typically involves a multi-step process that includes the formation of the propargyloxyethoxy intermediate and subsequent reaction with a chloromethyl ketone derivative. Advanced synthetic methods, such as transition metal-catalyzed cross-coupling reactions, have been employed to improve the efficiency and yield of the synthesis. These methods not only enhance the scalability of production but also reduce environmental impact by minimizing waste generation.

In addition to its therapeutic applications, chloro2-(prop-2-yn-1-yloxy)ethoxymethanone has found use in analytical chemistry as a derivatizing agent. The compound can be used to modify analytes for enhanced detection and quantification in various analytical techniques, such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS). This application is particularly relevant in forensic science and environmental monitoring, where accurate and sensitive detection of trace compounds is essential.

The safety profile of chloro2-(prop-2-yn-1-yloxy)ethoxymethanone has been extensively evaluated through toxicological studies. These studies have demonstrated that the compound exhibits low toxicity at therapeutic concentrations, making it suitable for use in pharmaceutical formulations. However, appropriate handling and storage precautions should be observed to ensure safety during laboratory and industrial applications.

In conclusion, chloro2-(prop-2-yn-1-yloxy)ethoxymethanone (CAS No. 2174001-17-1) is a versatile compound with significant potential in medicinal chemistry, pharmaceutical research, and analytical chemistry. Its unique chemical structure and reactivity make it an attractive candidate for various applications, from targeted drug delivery systems to antiviral agents and derivatizing agents. Ongoing research continues to uncover new possibilities for this intriguing molecule, further solidifying its importance in modern scientific endeavors.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)